Kathmere Capital Management »

Oramed Pharm shares owned by Kathmere Capital Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Kathmere Capital Management from 13F filings

Historical chart of Kathmere Capital Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Kathmere Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Kathmere Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $51k 15k 3.40

More positions owned by Kathmere Capital Management

Ishares Tr Msci Usa Value (VLUE)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Msci Usa Mmentm (MTUM)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Apple (AAPL)
Ishares Tr Ibonds Dec2026 (IBDR)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Tr Ibds Dec28 Etf (IBDT)
Ishares Tr Ibonds Dec 2030 (IBDV)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Ibonds Dec 29 (IBDU)

View all positions for Kathmere Capital Management

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Mercer Global Advisors
SB Capital Management
Murchinson
Boothbay Fund Management
Marshall Wace
Rathbones Brothers
Dimensional Fund Advisors
Wells Fargo & Company
Comprehensive Portfolio Management
Renaissance Technologies
Bank of America Corporation
O'shaughnessy Asset Management
Citadel Advisors

View all funds holding Oramed Pharm